Transdermal Peptide Hormone Replacement Patches Market

FMI opines the peptide hormone replacement patch market was valued at USD 68.5 million in 2025. The industry is expected to cross USD 77.0 million in 2026 and USD 247.8 million by 2036. Parathyroid hormone analogues (abaloparatide, teriparatide, PTH 1-34) is poised to lead by Hormone type with 46.0% share in 2026 and Coated solid microneedle / solid microstructured transdermal systems is estimated to dominate by Patch technology through 2036.